COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana

Not Applicable

Completed

• Conditions: Vaccine Refusal; Vaccine Hesitancy; Covid19
• Interventions: Behavioral: COVID-19 Vaccine Education at the Point of COVID-19 Testing

• Registration Number: NCT04939506
• Lead Sponsor: Xavier University of Louisiana.

Brief Summary

This project is a 2-year study to investigate vaccine hesitancy and vaccine completion among vulnerable communities in the Southeastern Louisiana region. This study will be used to track COVID-19 vaccine completion among patients who seek testing, either as in-person or purchasing at home COVID testing, from pharmacies, urgent cares and clinics using a rapid vaccine education model delivered at the point of care.

Detailed Description

This project is a 2-year study to investigate vaccine hesitancy and vaccine completion among vulnerable communities in the Southeastern Louisiana region. This study will be used to track COVID-19 vaccine completion among patients who seek testing, either as in-person or purchasing at home COVID testing, from pharmacies, urgent cares and clinics. The proposal will introduce a rapid vaccination education model to be delivered at the point of COVID-19 testing by pharmacy students, pharmacy technicians, nurse's aides and other health care personnel and includes monitoring for COVID-19 vaccine completion among enrolled patients. Investigators anticipate an increase in COVID-19 vaccine completion rates for those who participate in the rapid vaccination education model.

Study Timeline

• Study First Submitted: 2021-06-22
• Study First Submitted QC: 2021-06-24
• Study First Posted: 2021-06-25
• Study Start: 2022-09-01
• Primary Completion: 2023-11-30
• Study Completion: 2024-01-25
• Status Verified: 2024-02
• Last Update Submitted: 2024-02-21
• Last Update Posted: 2024-02-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 379

Inclusion Criteria

• Unvaccinated adult participants, 18-99 years of age, able to provide informed consent, and to communicate in English, Spanish or Arabic. Also, individuals with incomplete vaccination (primary series or COVID-19 booster).

Exclusion Criteria

• Persons fully vaccinated for COVID-19 (including primary series and boosters), persons with any documented allergies to components of the COVID-19 vaccines, or contraindications to receiving a COVID-19 vaccine.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Participants Which Receive COVID-19 Vaccine Education at the Point of COVID-19 Testing	COVID-19 Vaccine Education at the Point of COVID-19 Testing	Vaccine education will be focused on addressing misinformation and concerns in a culturally competent manner with referral to resources. The vaccine education model will be translated to reach minority groups including African Americans, Vietnamese Americans and Hispanic Americans.

Primary Outcome Measures

Name	Time	Method
COVID-19 Vaccine Completion	9 months intervention	COVID-19 vaccination verified by the Louisiana Links© system

Secondary Outcome Measures

Name	Time	Method
Vaccine Hesitancy Likelihood Scale	9 months post intervention	Measured on a 5-point scale indicating likelihood to be vaccinated. The scale ranges from 1 (Not at all likely to be vaccinated), 2 (Not likely to be vaccinated), 3 (No opinion/Undecided about vaccination), 4 (Likely to be vaccinated) to 5 (Very likely to be vaccinated)

Trial Locations

Locations (1)

Xavier University of Louisiana; 🇺🇸 New Orleans, Louisiana, United States